Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hiwasa

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Biological Chemistry Hoppe-Seyler|May 1, 1988
Possible involvement of protease inhibitor ras proteins in malignant transformationT Hiwasa
Oncology Reports|May 20, 2011
Ras inhibitorsT Hiwasa
Cancer Letters|January 19, 1996
Nuclear localization of procathepsin L/MEP in ras-transformed mouse fibroblastsT Hiwasa, S Sakiyama
Biochemical and Biophysical Research Communications|November 22, 1995
Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cellsT Hiwasa, E Kominami
Biochemical and Biophysical Research Communications|September 14, 1986
Altered properties of cAMP-dependent protein kinase in H-ras-transformed NIH3T3 cellsT Hiwasa, S Sakiyama
Gan|January 1, 1984
Disorganization of microfilaments caused by tumor promoters in mouse fibroblastsS Sakiyama, T Hiwasa
Biochemical and Biophysical Research Communications|October 24, 1998
Suppression of transformed phenotypes of Ha-ras-transformed NIH3T3 cells by caspase-2T Hiwasa, A Nakagawara
Anticancer Research|July 1, 1996
Growth-suppressive activities of serine protease inhibitors, ONO-3403 and ONO-5046, toward normal and transformed murine fibroblastsT Hiwasa, M Ohkoshi
Cancer Research|May 1, 1986
Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells after treatment with tumor promoters, chemical carcinogens, metal salts, and heat shockT Hiwasa, S Sakiyama
Oncology Reports|May 19, 2011
Growth-suppressive activities of serine protease inhibitors, FOY-305, ONO-3403 and FO-349 toward human carcinoma cellsM Ohkoshi, T Denda, T Hiwasa
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Biological Chemistry Hoppe-Seyler|May 1, 1988
Possible involvement of protease inhibitor ras proteins in malignant transformationT Hiwasa
Oncology Reports|May 20, 2011
Ras inhibitorsT Hiwasa
Cancer Letters|January 19, 1996
Nuclear localization of procathepsin L/MEP in ras-transformed mouse fibroblastsT Hiwasa, S Sakiyama
Biochemical and Biophysical Research Communications|November 22, 1995
Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cellsT Hiwasa, E Kominami
Biochemical and Biophysical Research Communications|September 14, 1986
Altered properties of cAMP-dependent protein kinase in H-ras-transformed NIH3T3 cellsT Hiwasa, S Sakiyama
Gan|January 1, 1984
Disorganization of microfilaments caused by tumor promoters in mouse fibroblastsS Sakiyama, T Hiwasa
Biochemical and Biophysical Research Communications|October 24, 1998
Suppression of transformed phenotypes of Ha-ras-transformed NIH3T3 cells by caspase-2T Hiwasa, A Nakagawara
Anticancer Research|July 1, 1996
Growth-suppressive activities of serine protease inhibitors, ONO-3403 and ONO-5046, toward normal and transformed murine fibroblastsT Hiwasa, M Ohkoshi
Cancer Research|May 1, 1986
Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells after treatment with tumor promoters, chemical carcinogens, metal salts, and heat shockT Hiwasa, S Sakiyama
Oncology Reports|May 19, 2011
Growth-suppressive activities of serine protease inhibitors, FOY-305, ONO-3403 and FO-349 toward human carcinoma cellsM Ohkoshi, T Denda, T Hiwasa
Pageof 6